Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 5.5% After Analyst Downgrade
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) fell 5.5% during mid-day trading on Monday after Citigroup downgraded the stock from a buy rating to a neutral rating. Citigroup now has a $24.00 price target on the stock, down from their previous price target of $35.00. Tandem Diabetes Care traded as low as $20.91 […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) fell 5.5% during mid-day trading on Monday after Citigroup downgraded the stock from a buy rating to a neutral rating. Citigroup now has a $24.00 price target on the stock, down from their previous price target of $35.00. Tandem Diabetes Care traded as low as $20.91 […]
